Impact of Dapagliflozin Adjunctive Therapy on the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease Stages 2-5: A systematic review and meta-analysis.
Dapagliflozin 輔助療法對於 2 型糖尿病及慢性腎病 2-5 期患者慢性腎病進展的影響:系統性回顧與統合分析。
Sultan Qaboos Univ Med J 2024-09-05
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.
糖尿病對鈉葡萄糖共同轉運蛋白-2抑制劑對腎臟結果影響的合作性大型安慰劑對照試驗的荟萃分析。
Lancet 2023-08-16
Evaluation of the Pharmacokinetics of Dapagliflozin in Patients With Chronic Kidney Disease With or Without Type 2 Diabetes Mellitus.
慢性腎臟病患者合併或不合併2型糖尿病的 Dapagliflozin 藥物動力學評估。
J Clin Pharmacol 2023-06-01
Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysis.
評估現代腎保護劑在預防第2型糖尿病患者腎複合結果進展中的影響:網絡荟萃分析。
Diabetes Ther 2023-02-24
Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients With Diabetes and Chronic Kidney Disease (CKD): A Meta-analysis of Randomized Control Trials.
SGLT2抑制劑在糖尿病和慢性腎臟病患者中的療效和安全性:隨機對照試驗的荟萃分析。
Cureus 2023-01-03
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study.
基於基線糖尿病藥物,DAPA-CKD 研究中達帕格列酮的功效:預先確定的分析。
Diabetes Care 2023-09-18
The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis.
非糖尿病慢性腎臟病患者中SGLT2抑制劑的療效和安全性:系統性回顧和荟萃分析。
Int Urol Nephrol 2023-10-30
Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis.
糖尿病腎病患者中鈉葡萄糖共同轉運蛋白2抑制劑加標準治療的療效和安全性:系統回顧和荟萃分析。
J Diabetes Complications 2023-06-13
Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis.
慢性腎臟病患者中鈉葡萄糖共同轉運蛋白2抑制劑的療效和安全性:系統性回顧和荟萃分析。
Int Urol Nephrol 2024-04-13
Cardiovascular Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Updated Meta-Analysis.
二型糖尿病合併慢性腎臟病患者接受鈉葡萄糖共同轉運蛋白2抑制劑治療的心血管結果:系統性回顧與更新的荟萃分析。
Korean Circ J 2024-06-11
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysis.
SGLT2 抑制劑與各類腎病的腎臟結果:系統性回顧與統合分析。
Clin J Am Soc Nephrol 2024-09-19